Ftse Mib
37.044,37
-0,21%
DAX
21.928,25
0,07%
S&P 500
6.083,57
0,36%
NASDAQ
19.791,99
0,51%
Bitcoin
97.687,13
1,15%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biora Therapeutics Inc (BIOR) Biora Therapeutics Inc (BIOR) Notizie

Biora Therapeutics Inc

BIOR
0,5597
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/12/202414:00GLOBEBiora Therapeutics Undertakes Chapter 11 Sale Process to..
10/12/202413:00EDGAR2Form 8-K - Current report
15/11/202422:05EDGAR2Form 8-K - Current report
14/11/202414:00GLOBEBiora Therapeutics Provides Corporate Update..
07/11/202422:30GLOBEBiora Therapeutics to Report Third Quarter 2024 Financial..
29/10/202421:43EDGAR2Form 8-K - Current report
29/10/202413:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/10/202413:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/10/202413:24EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/10/202413:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/10/202413:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/10/202413:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/10/202413:00GLOBEBiora Therapeutics Announces $3 Million Registered Direct..
28/10/202413:00GLOBEBiora Therapeutics Shares Progress on Smaller BioJet™..
23/10/202423:24EDGAR2Form DEF 14A - Other definitive proxy statements
14/10/202414:00GLOBEBiora Therapeutics to Reveal 00-Size BioJet™ Device at the..
11/10/202422:52EDGAR2Form PRE 14A - Other preliminary proxy statements
11/10/202414:00EDGAR2Form 8-K - Current report
09/10/202423:40EDGAR2Form SC 13D/A - General Statement of Acquisition of..
07/10/202414:00GLOBEBiora Therapeutics to Present at the 19th Annual Peptide..
30/9/202414:00GLOBEBiora Therapeutics Announces Award-Winning Abstract to be..
16/9/202422:30EDGAR2Form DEF 14A - Other definitive proxy statements
13/9/202422:05EDGAR2Form 8-K - Current report
13/9/202416:37EDGAR2Form SC 13D/A - General Statement of Acquisition of..
09/9/202414:00GLOBEBiora Therapeutics Achieves ISO 13485 Certification
05/9/202412:02EDGAR2Form 8-K - Current report
04/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
03/9/202422:31EDGAR2Form PRE 14A - Other preliminary proxy statements
28/8/202414:00GLOBEBiora Therapeutics Announces Positive Nasdaq Listing..
26/8/202414:00GLOBEBiora Therapeutics to Present at H.C. Wainwright 26th Annual..
23/8/202423:13EDGAR2Form S-3 - Registration statement under Securities Act of..
23/8/202423:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/8/202423:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/8/202423:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/8/202423:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/8/202423:00EDGAR2Form 8-K - Current report
20/8/202422:15EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
16/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202403:58EDGAR2Form SC 13D/A - General Statement of Acquisition of..
12/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:15EDGAR2Form 8-K - Current report
12/8/202422:15GLOBEBiora Therapeutics Provides Corporate Update..
12/8/202422:05EDGAR2Form 8-K - Current report
12/8/202422:05GLOBEBiora Therapeutics Announces Funding Agreement with Existing..
08/8/202422:30GLOBEBiora Therapeutics to Report Second Quarter 2024 Financial..
06/8/202414:00GLOBEBiora Therapeutics to Participate in Canaccord Genuity 44th..
18/7/202414:05EDGAR2Form 8-K - Current report
18/7/202414:00GLOBEBiora Therapeutics Announces Supplemental Data from Phase 1..
09/7/202403:42EDGAR2Form SC 13D/A - General Statement of Acquisition of..
Apertura: Min: Max:
Chiusura: 0,5597

La tua Cronologia

NASDAQ
BIOR
Biora Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci